Back

Cellular targets for drug therapy in HCM

13 April 2024 (08:30 - 08:45)
Organised by: Logo
Congress Presentation Part of: Hypertrophic and dilated cardiomyopathy: from molecular targets to therapy Cardiomyopathies CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Raffaele Coppini

University of Florence, Florence (Italy)

3 More presentations in this session

Presentation thumbnail
Genetic basis and molecular mechanisms in dilated cardiomyopathy (DCM)
Professor J. van der Velden (Amsterdam, NL)
Slides
Presentation thumbnail
Gene therapy in laminopathies and DCM
Doctor A. Tijsen (Amsterdam, NL)
Slides
Presentation thumbnail
Meteorin-like regulates cardiac hypertrophy and associated metabolic plasticity during gestation and lactation
Mr A. Blasco-Roset (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Hypertrophic and dilated cardiomyopathy: from molecular targets to therapy

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 08:30 CET
You may be interested in
thumbnail
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
17 May 2025
thumbnail
Congress Presentation
Betablockers or calcium channel blockers in hypertrophic cardiomyopathy
22 May 2023
thumbnail
Congress Presentation
Human-based computational and experimental investigation of disease mechanisms in mutation-specific hypertrophic cardiomyopathy
24 April 2021
thumbnail
Congress Presentation
Myocardial work in hypertrophic cardiomyopathy - a new non-invasive parameter for segmental myocardial function?
9 December 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources